SK17594A3 - Pyrazine derivatives, their preparation and their use - Google Patents

Pyrazine derivatives, their preparation and their use Download PDF

Info

Publication number
SK17594A3
SK17594A3 SK175-94A SK17594A SK17594A3 SK 17594 A3 SK17594 A3 SK 17594A3 SK 17594 A SK17594 A SK 17594A SK 17594 A3 SK17594 A3 SK 17594A3
Authority
SK
Slovakia
Prior art keywords
alkyl
group
formula
substituted
amino
Prior art date
Application number
SK175-94A
Other languages
English (en)
Slovak (sk)
Inventor
Herbert Koppe
Georg Speck
Klaus Stockhaus
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/de
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/de
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of SK17594A3 publication Critical patent/SK17594A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
SK175-94A 1991-08-16 1992-07-31 Pyrazine derivatives, their preparation and their use SK17594A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (de) 1991-08-16 1991-08-16 Neue pyrazinderivate, ihre herstellung und verwendung
DE19914130461 DE4130461A1 (de) 1991-09-13 1991-09-13 Neue pyrazinderivate, ihre herstellung und verwendung
PCT/EP1992/001738 WO1993004048A1 (de) 1991-08-16 1992-07-31 Neue pyrazinderivative, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
SK17594A3 true SK17594A3 (en) 1994-12-07

Family

ID=25906394

Family Applications (1)

Application Number Title Priority Date Filing Date
SK175-94A SK17594A3 (en) 1991-08-16 1992-07-31 Pyrazine derivatives, their preparation and their use

Country Status (23)

Country Link
EP (1) EP0598770B1 (no)
JP (1) JPH06509798A (no)
AT (1) ATE159250T1 (no)
AU (1) AU669122B2 (no)
CA (1) CA2115755A1 (no)
CZ (1) CZ280760B6 (no)
DE (1) DE59208974D1 (no)
DK (1) DK0598770T3 (no)
ES (1) ES2108129T3 (no)
FI (1) FI940696A0 (no)
GR (1) GR3025742T3 (no)
HK (1) HK1003137A1 (no)
HU (1) HUT67661A (no)
IE (1) IE922592A1 (no)
IL (1) IL102814A0 (no)
MX (1) MX9204637A (no)
NO (1) NO301542B1 (no)
NZ (1) NZ243959A (no)
RU (1) RU2124008C1 (no)
SG (1) SG46307A1 (no)
SK (1) SK17594A3 (no)
TW (1) TW213903B (no)
WO (1) WO1993004048A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4337609A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5760230A (en) * 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
AU4952700A (en) 1999-06-03 2000-12-28 Takeda Chemical Industries Ltd. Pernasal preparations
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
OA12790A (en) * 2002-03-13 2006-07-10 Janssen Pharmaceutica Nv New inhibitors of histone deacetylase.
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
JP2007504136A (ja) 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2597460A1 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
DE102008061247A1 (de) 2008-12-10 2010-06-24 Christian-Albrechts-Universität Zu Kiel Inhibitoren der Dimethylarginin Dimethylaminohydrolase
JP5695200B2 (ja) * 2010-09-10 2015-04-01 ハンジョウ ベンシェン ファーマシューティカル シーオー., エルティーディー.Hangzhou Bensheng Pharmaceutical Co., Ltd. 複素環アミノベルバミン誘導体、その調製方法及び使用
CN110041291B (zh) * 2018-01-15 2021-02-26 北京采瑞医药科技研究院有限公司 一种玛咖酰胺衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299931A (no) * 1962-10-30
US3527758A (en) * 1967-04-13 1970-09-08 Merck & Co Inc Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine
US3539569A (en) * 1968-08-21 1970-11-10 Merck & Co Inc Preparation of pyrazinoylguanidines from pyrazinoylureas
NL7803906A (nl) * 1978-04-12 1979-10-16 Noordvos Schroeven Bv Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof.

Also Published As

Publication number Publication date
ATE159250T1 (de) 1997-11-15
GR3025742T3 (en) 1998-03-31
HUT67661A (en) 1995-04-28
FI940696A (fi) 1994-02-15
JPH06509798A (ja) 1994-11-02
SG46307A1 (en) 1998-02-20
AU669122B2 (en) 1996-05-30
CZ280760B6 (cs) 1996-04-17
NO940523D0 (no) 1994-02-15
CA2115755A1 (en) 1993-03-04
HU9400430D0 (en) 1994-05-30
DK0598770T3 (da) 1997-12-15
HK1003137A1 (en) 1998-10-09
EP0598770A1 (de) 1994-06-01
NZ243959A (en) 1995-07-26
WO1993004048A1 (de) 1993-03-04
TW213903B (no) 1993-10-01
EP0598770B1 (de) 1997-10-15
MX9204637A (es) 1993-02-01
ES2108129T3 (es) 1997-12-16
NO940523L (no) 1994-02-15
IE922592A1 (en) 1993-02-24
IL102814A0 (en) 1993-01-31
RU94015265A (ru) 1997-02-20
RU2124008C1 (ru) 1998-12-27
NO301542B1 (no) 1997-11-10
AU2387092A (en) 1993-03-16
FI940696A0 (fi) 1994-02-15
CZ33794A3 (en) 1994-07-13
DE59208974D1 (de) 1997-11-20

Similar Documents

Publication Publication Date Title
SK17594A3 (en) Pyrazine derivatives, their preparation and their use
DK2346837T3 (en) Methods for preparing quinazolinone derivatives
SK282080B6 (sk) Substituované salicylové kyseliny a ich použitie
KR20060009900A (ko) 피페리디닐- 및 피페라지닐-알킬 카르바메이트 유도체,그의 제조 방법 및 그의 치료 용도
FI63934C (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-(4-substituerad piperidino)kinazoliner anvaendbara foer behandling av brstande hjaertfunktion
JP6704422B2 (ja) キナゾリン誘導体の塩およびその製造方法
KR20010072439A (ko) 치환된 4-아미노-2-아릴-피리미딘, 이의 제조방법 및용도, 및 이를 함유하는 약제학적 제제
WO2014078309A1 (en) Cannabinoid receptor mediating compounds
EP3303325A1 (en) Cannabinoid receptor mediating compounds
US5210086A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy
JP4623354B2 (ja) 新規ピリミジン誘導体及び新規ピリジン誘導体
US20230067045A1 (en) Thiophene[2,3-d]pyrimidine derivative dk6-1 and its preparation method and application
US5229392A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy
EP0690051B1 (en) Diazacycloalkanealkylsulfonamide derivative
DE4127026A1 (de) Neue pyrazinderivate, ihre herstellung und verwendung
US5330985A (en) 2-amino-N-[[4-(aminocarbonyl)pyrimidin-2-yl]amino]-alkyl]pyrimidine-4-carboxamide derivatives, their preparation and pharmaceutical compositions containing them
CN110563656A (zh) 嘧啶类小分子化合物及在制备抗分枝杆菌药物中的用途
US6235738B1 (en) Diphenyl-substituted heterocycles with 6-membered ring, processes for the preparation thereof and the use thereof as medicaments
US2465568A (en) Pyrimidine compounds
US5420130A (en) 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics
JP2846070B2 (ja) カルボキシイミダミド誘導体
JP2010501007A (ja) チオ尿素化合物
DE4130461A1 (de) Neue pyrazinderivate, ihre herstellung und verwendung
CS218022B1 (cs) Deriváty 2-piperazino-4-amino-6,7-dimethoxychinazolina a způsoby jejich přípravy
LV14984B (lv) 2-Fenilamino-4-(piridin-3-il)-6-perfluoralkilpirimidīni